Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    July 2022
  1. POWELL J, Porter E, Field S, O'Connell NH, et al
    Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.
    Mycoses. 2022;65:770-779.
    >> Share

  2. SKAASTRUP KN, Astvad KMT, Arendrup MC, Jemec GBE, et al
    Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
    Mycoses. 2022;65:741-746.
    >> Share

    June 2022
  3. RONG T, Zhu P, Zhou Y, Li Q, et al
    Altered skin fungal and bacterial community compositions in tinea capitis.
    Mycoses. 2022 Jun 11. doi: 10.1111/myc.13480.
    >> Share

  4. EGGER M, Hoenigl M, Thompson GR 3rd, Carvalho A, et al
    Let's talk about sex characteristics-As a risk factor for invasive fungal diseases.
    Mycoses. 2022;65:599-612.
    >> Share

  5. FUHR R, Cook D, Ridden J, Nield K, et al
    Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
    Mycoses. 2022;65:661-669.
    >> Share

  6. NYUYKONGE B, Lim W, van Amelsvoort L, Bonifaz A, et al
    Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Mycoses. 2022;65:650-655.
    >> Share

    May 2022
  7. ZIAKA M, Papakonstantinou E, Vasileiou E, Chorafa E, et al
    Pediatric cutaneous mucormycosis: case report and review of the literature.
    Mycoses. 2022 May 5. doi: 10.1111/myc.13452.
    >> Share

  8. ATSU N, Ergin C, Caf N, Turkoglu Z, et al
    Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples.
    Mycoses. 2022 May 4. doi: 10.1111/myc.13450.
    >> Share

  9. CORREIA NS, Balbinot RTS, Bonacorsi C, Donofrio FC, et al
    Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.
    Mycoses. 2022;65:560-566.
    >> Share

    April 2022
  10. ZHU X, Zheng B, Cai W, Zhang J, et al
    Deep learning-based diagnosis models for onychomycosis in dermoscopy.
    Mycoses. 2022;65:466-472.
    >> Share

  11. NASR M, Abd-Elhamid N, Abd-Allah D, Elkholy B, et al
    Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
    Mycoses. 2022;65:402-410.
    >> Share

  12. SONG G, Zhang M, Liu W, Liang G, et al
    Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020.
    Mycoses. 2022;65:440-448.
    >> Share

  13. BLUME-PEYTAVI U, Tosti A, Falques M, Tamarit ML, et al
    A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Mycoses. 2022;65:392-401.
    >> Share

    March 2022
  14. WIDATY S, Oktarina C, Suling PL, Niode NJ, et al
    Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia.
    Mycoses. 2022;65:323-330.
    >> Share

  15. TRAVE I, Cozzani E, Canepa P, Verdiani S, et al
    Real-life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis.
    Mycoses. 2022;65:317-322.
    >> Share

    February 2022
  16. VILLACORTA CARI E, Leedy N, Ribes JA, Soria J, et al
    Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients.
    Mycoses. 2022;65:239-246.
    >> Share

    January 2022
  17. WANG S, Song Y, Wan Z, Chen W, et al
    Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis.
    Mycoses. 2022;65:35-44.
    >> Share

  18. POESTER VR, Stevens DA, Basso RP, Munhoz LS, et al
    CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil.
    Mycoses. 2022;65:30-34.
    >> Share

  19. SHENOY MM, Rengasamy M, Dogra S, Kaur T, et al
    A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Mycoses. 2022;65:13-23.
    >> Share

    December 2021
  20. KHURANA A, Agarwal A, Singh A, Sardana K, et al
    Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Mycoses. 2021;64:1480-1488.
    >> Share

  21. LAROCHE L, Bourgeois N, Lachaud L, Rispail P, et al
    Epidemiological analysis of nail aspergillosis and non-dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France (1991-2019).
    Mycoses. 2021;64:1546-1553.
    >> Share

  22. GUARANA M, Nouer SA, Nucci M
    EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
    Mycoses. 2021;64:1542-1545.
    >> Share

  23. HE M, Zeng J, Mao Y, Zheng Y, et al
    Aetiological changes of tinea capitis in the Hubei area in 60 years: Focus on adult tinea capitis.
    Mycoses. 2021;64:1527-1534.
    >> Share

    November 2021
  24. RONG T, Li R, Ruojun W
    Dysbiosis of Skin Mycobiome in Atopic Dermatitis.
    Mycoses. 2021 Nov 24. doi: 10.1111/myc.13402.
    >> Share

  25. ELSNER K, Holstein J, Hilke FJ, Blumenstock G, et al
    Prevalence of Candida species in Psoriasis.
    Mycoses. 2021 Nov 17. doi: 10.1111/myc.13399.
    >> Share

  26. ZHANG W, Wu S, Wang X, Gao Y, et al
    Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis-A Six-year Retrospective Cohort Study.
    Mycoses. 2021;64:1422-1428.
    >> Share

  27. JHA K, Shaw D, Karim A, Narang T, et al
    Immunological response and clinical profile in patients with recurrent dermatophytosis.
    Mycoses. 2021;64:1429-1441.
    >> Share

  28. JAIN A, Dhamale S, Sardesai V
    Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India.
    Mycoses. 2021;64:1442-1447.
    >> Share

  29. SHAMSIZADEH F, Ansari S, Zarei Mahmoudabadi A, Hubka V, et al
    In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.
    Mycoses. 2021;64:1378-1386.
    >> Share

    October 2021
  30. SHARMA B, Nonzom S
    Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India.
    Mycoses. 2021 Oct 3. doi: 10.1111/myc.13378.
    >> Share

  31. NOWICKA D, Nawrot U
    Tinea pedis-An embarrassing problem for health and beauty-A narrative review.
    Mycoses. 2021;64:1140-1150.
    >> Share

  32. ZHAO Y, Gan M, Li L, Su H, et al
    Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence.
    Mycoses. 2021;64:1272-1278.
    >> Share

    September 2021
  33. BADIANE AS, Diongue K, Seck MC, Ndiaye M, et al
    Epidemiological aspects of superficial fungal infections in Koranic schools in two localities of Senegal (Thies and Touba).
    Mycoses. 2021;64:1132-1136.
    >> Share

    August 2021
  34. METIN MS, Elmas OF, Demirbas A, Erel O, et al
    The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis.
    Mycoses. 2021;64:947-953.
    >> Share

  35. GNAT S, Dylag M, Lagowski D, Zielinski J, et al
    Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
    Mycoses. 2021;64:967-975.
    >> Share

  36. SHAW D, Ghosh AK, Paul S, Singh S, et al
    Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes.
    Mycoses. 2021;64:926-935.
    >> Share

  37. SHARMA B, Nonzom S
    Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis.
    Mycoses. 2021;64:890-908.
    >> Share

  38. CHANG MJ, Qiu Y, Lipner SR
    Race reporting and representation in onychomycosis clinical trials: A systematic review.
    Mycoses. 2021;64:954-966.
    >> Share

    July 2021
  39. PHAM CVA, Rademacher F, Hinrichs H, Beck-Jendroschek V, et al
    Expression of epidermal antimicrobial peptides is increased in tinea pedis.
    Mycoses. 2021;64:763-770.
    >> Share

  40. DA COSTA B, Pippi B, Berlitz SJ, Carvalho AR, et al
    Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
    Mycoses. 2021;64:727-733.
    >> Share

  41. SINGH A, Singh P, Dingemans G, Meis JF, et al
    Evaluation of DermaGenius((R)) resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant Trichophyton species.
    Mycoses. 2021;64:721-726.
    >> Share

  42. ABDILLAH A, Packeu A, Khelaifia S, Ranque S, et al
    Intra- and inter-laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing.
    Mycoses. 2021;64:716-720.
    >> Share

  43. BADALI H, Canete-Gibas C, Patterson H, Sanders C, et al
    In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Mycoses. 2021;64:748-752.
    >> Share

  44. REINEL D
    Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice.
    Mycoses. 2021;64:694-700.
    >> Share

    June 2021
  45. DE LIMA GRYNSZPAN R, Carvalho Barreiros MDG, do Nascimento Paixao M, Fernandes MF, et al
    Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment.
    Mycoses. 2021 Jun 1. doi: 10.1111/myc.13331.
    >> Share

  46. GE LY, Liu J, Zheng HL, Mei H, et al
    Comprehensive genome and transcriptome analysis of the dermatophyte Trichophyton schoenleinii reveals the candidate pathogenic genes.
    Mycoses. 2021;64:624-633.
    >> Share

    May 2021
  47. CELESTRINO GA, Verrinder Veasey J, Benard G, Sousa MGT, et al
    Host immune responses in dermatophytes infection.
    Mycoses. 2021;64:477-483.
    >> Share

  48. SONG Y, Menezes da Silva N, Vicente VA, Quan Y, et al
    Comparative genomics of opportunistic Phialophora species involved in divergent disease types.
    Mycoses. 2021;64:555-568.
    >> Share

  49. ZHI H, Shen H, Zhong Y, Sang B, et al
    Tinea capitis in children: A single-institution retrospective review from 2011 to 2019.
    Mycoses. 2021;64:550-554.
    >> Share

  50. GNAT S, Lagowski D, Nowakiewicz A, Dylag M, et al
    Complementary effect of mechanism of multidrug resistance in Trichophyton mentagrophytes isolated from human dermatophytoses of animal origin.
    Mycoses. 2021;64:537-549.
    >> Share

  51. STARACE M, Ambrogio F, Bruni F, Piraccini BM, et al
    Dermatophytic melanonychia: A case series of an increasing disease.
    Mycoses. 2021;64:511-519.
    >> Share

  52. WANG HN, Shang CS, Yang SJ, Shih IH, et al
    Clinical and epidemiological characteristics of tinea capitis in northern Taiwan during 2014-2019: An unusual bimodal distribution of patients and comparison of paediatric and adult cases.
    Mycoses. 2021;64:484-494.
    >> Share

    April 2021
  53. MULLER VL, Kappa-Markovi K, Hyun J, Georgas D, et al
    Tinea capitis et barbae caused by Trichophyton tonsurans: A retrospective cohort study of an infection chain after shavings in barber shops.
    Mycoses. 2021;64:428-436.
    >> Share

  54. DA CRUZ BAHIENSE ROCHA I, Terra PPD, Cardoso de Oliveira R, Lubianca Zanotti R, et al
    Molecular-based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espirito Santo-Brazil.
    Mycoses. 2021;64:420-427.
    >> Share

  55. ZARESHAHRABADI Z, Totonchi A, Rezaei-Matehkolaei A, Ilkit M, et al
    Molecular identification and antifungal susceptibility among clinical isolates of dermatophytes in Shiraz, Iran (2017-2019).
    Mycoses. 2021;64:385-393.
    >> Share

  56. BONGOMIN F, Olum R, Nsenga L, Namusobya M, et al
    Estimation of the burden of tinea capitis among children in Africa.
    Mycoses. 2021;64:349-363.
    >> Share

  57. WANG R, Huang C, Zhang Y, Li R, et al
    Invasive dermatophyte infection: A systematic review.
    Mycoses. 2021;64:340-348.
    >> Share

    March 2021
  58. MORENO-SABATER A, Ouali N, Chasset F, Frances C, et al
    Severe onychomycosis management with oral terbinafine in a kidney transplantation setting: Clinical follow-up by image analysis.
    Mycoses. 2021;64:309-315.
    >> Share

  59. ANSARI S, Ahmadi B, Hedayati MT, Nouripour-Sisakht S, et al
    Investigation of in vitro antifungal susceptibility testing and genetic diversity of clinical isolates of Trichophyton benhamiae and Trichophyton eriotrephon in Iran.
    Mycoses. 2021;64:316-323.
    >> Share

  60. CURATOLO R, Juricevic N, Leong C, Bosshard PP, et al
    Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method.
    Mycoses. 2021;64:282-291.
    >> Share

    February 2021
  61. LECERF P, Abdy S, Vollono L, Pastushenko I, et al
    Direct examination, histopathology and fungal culture for the diagnosis of onychomycosis: A retrospective, comparative study on 2245 specimens.
    Mycoses. 2021;64:187-193.
    >> Share

  62. ALEOHIN N, Bar J, Bar-Ilan E, Samuelov L, et al
    Laboratory monitoring during antifungal treatment of paediatric tinea capitis.
    Mycoses. 2021;64:157-161.
    >> Share

    January 2021
  63. KATO H, Foster CM, Karri K
    Incidence, predisposing conditions, and outcomes of cutaneous mucormycosis: A national database study.
    Mycoses. 2021 Jan 21. doi: 10.1111/myc.13245.
    >> Share

  64. LAN Y, Lu S, Zhang J
    Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review.
    Mycoses. 2021;64:18-23.
    >> Share

    November 2020
  65. YU J, Liu WD, Tong ZS, Yu N, et al
    Aetiology of superficial fungal infections of the foot in urban outpatients in mainland China: A multicentre, prospective case study.
    Mycoses. 2020;63:1235-1243.
    >> Share

  66. PEREZ-CANTERO A, Guarro J
    Sarocladium and Acremonium infections: New faces of an old opportunistic fungus.
    Mycoses. 2020;63:1203-1214.
    >> Share

    August 2020
  67. ALBERDI E, Gomez C
    Methylene blue vs methyl aminolevulinate photodynamic therapy in combination with oral terbinafine in the treatment of severe dermatophytic toenail onychomycosis: Short- and long-term effects.
    Mycoses. 2020;63:859-868.
    >> Share

  68. ANASTASOPOULOU A, DiPippo AJ, Kontoyiannis DP
    Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
    Mycoses. 2020;63:787-793.
    >> Share

  69. ENDRINGER PINTO F, Bagger C, Kunze G, Joly-Tonetti N, et al
    Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
    Mycoses. 2020;63:869-875.
    >> Share

  70. LIANG G, Zheng X, Song G, Zhang M, et al
    Adult tinea capitis in China: A retrospective analysis from 2000 to 2019.
    Mycoses. 2020;63:876-888.
    >> Share

    June 2020
  71. DE ABREU MH, Bitencourt TA, Franco ME, Moreli IS, et al
    Expression of genes containing tandem repeat patterns involved in the fungal-host interaction and in the response to antifungals in Trichophyton rubrum.
    Mycoses. 2020;63:610-616.
    >> Share

  72. GAMAGE H, Sivanesan P, Hipler UC, Elsner P, et al
    Superficial fungal infections in the department of dermatology, University Hospital Jena: A 7-year retrospective study on 4556 samples from 2007 to 2013.
    Mycoses. 2020;63:558-565.
    >> Share

    May 2020
  73. KERMANI F, Moosazadeh M, Hedayati MT, Abastabar M, et al
    Molecular epidemiology of Tinea gladiatorum in contact sports in northern Iran.
    Mycoses. 2020;63:509-516.
    >> Share

  74. NAEIMIFAR A, Samadi A, Ahmad Nasrollahi S, Fattahi A, et al
    Efinaconazole topical solution 10%: Formulation and efficacy assessment in the treatment of toenail onychomycosis.
    Mycoses. 2020;63:517-524.
    >> Share

    March 2020
  75. YAO L, Song Y, Zhou JF, Cui Y, et al
    Epidemiological and clinical comparisons of paediatric and adult sporotrichosis in Jilin Province, China.
    Mycoses. 2020;63:308-313.
    >> Share

  76. LAGOWSKI D, Gnat S, Nowakiewicz A, Osinska M, et al
    Comparison of in vitro activities of 11 antifungal agents against Trichophyton verrucosum isolates associated with a variety hosts and geographical origin.
    Mycoses. 2020;63:294-301.
    >> Share

  77. BADIANE AS, Ndiaye M, Diongue K, Diallo MA, et al
    Geographical distribution of mycetoma cases in senegal over a period of 18 years.
    Mycoses. 2020;63:250-256.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016